Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New DNA vaccine provides both tumor-specific immunity and antiangiogenesis

Sep. 25, 2001

Allovectin-7 phase III registration trial in metastatic melanoma now fully enrolled

Sep. 20, 2001

Rituximab now available in Japan

Sep. 14, 2001

NeoPharm seeks orphan drug status for IL-13-PE38

Sep. 14, 2001

Provenge advances towards 2002 BLA submission

Sep. 13, 2001

AltaRex completes primary analysis of OvaRex clinical trial

Sep. 7, 2001

Positive preliminary phase II data reported for Stressgen's HspE7

Sep. 7, 2001

Major European launch announced for new CLL therapy

Sep. 7, 2001

Schering AG to amend collaboration agreement with MediGene

Sep. 6, 2001

Biomira and Merck KGaA to meet with FDA regarding Theratope vaccine

Aug. 27, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...